Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Pyrrole derivatives with HIV reverse transcriptase-inhibitory activity described in patent

Feb. 19, 2002

ViroLogic technology used to evaluate Panacos HIV drug candidates

Feb. 18, 2002

GenVec signs contract for preventive AIDS vaccine

Feb. 14, 2002

Viread approved in E.U. for treatment of HIV

Feb. 11, 2002

Once-daily one-tablet formulation of Sustiva approved

Feb. 6, 2002

Clinical testing of candidate HIV vaccine developed at GSK commences in U.S.

Feb. 5, 2002

Boehringer Ingelheim prepares non-nucleoside compounds that inhibit HIV reverse transcriptase

Feb. 1, 2002

Agouron terminates HIV target collaboration with PPD Discovery

Feb. 1, 2002

Italian researchers identify promising lead in search for third-generation NNRTIs

Jan. 31, 2002

Epimmune reschedules IND filing for lead HIV vaccine candidate

Jan. 30, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...